Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
Rognoni C, Marchetti M, Quaglini S, Liberato NL
Record Status
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Bibliographic details
Rognoni C, Marchetti M, Quaglini S, Liberato NL. Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis. Journal of Thrombosis and Thrombolysis 2014